2024

2024–present
Ongoing remission cases and gene-editing strategies inspired by transplant cures.

2023

Düsseldorf patient: another confirmed cure strengthens proof of concept.

2022

City of Hope patient: durable remission in an older adult (Jensen et al.).

New York patient: cord blood-based cure/remission expands the concept (Hsu et al.).

2019

London patient: second durable HIV remission/cure reported (Gupta et al.).

2009
Berlin patient: first person cured of HIV after allogeneic HSCT from a CCR5A32/A32 donor (Hütter et al.).
1996
Combination ART transforms HIV survival but not cure.
CCR5 identified as a key HIV co-receptor; becomes a major therapeutic clue.

1983

HIV Identified

Lead Investigators

Lishomwa (Lish) Ndhlovu, MD, PhD Herbert J. and Ann L. Siegel Distinguished Professor, Professor of Immunology in Medicine
Jonah B. Sacha, PhD, Professor and Chief, Division of Pathobiology and Immunology, Oregon National Primate Research Center

NIH Merit Award Grant #R37AI189285
TRANSLATE